Alzheimer’s Disease: Exploring Pathophysiological Hypotheses and the Role of Machine Learning in Drug Discovery
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(3), P. 1004 - 1004
Published: Jan. 24, 2025
Alzheimer’s
disease
(AD)
is
a
major
neurodegenerative
dementia,
with
its
complex
pathophysiology
challenging
current
treatments.
Recent
advancements
have
shifted
the
focus
from
traditionally
dominant
amyloid
hypothesis
toward
multifactorial
understanding
of
disease.
Emerging
evidence
suggests
that
while
amyloid-beta
(Aβ)
accumulation
central
to
AD,
it
may
not
be
primary
driver
but
rather
part
broader
pathogenic
process.
Novel
hypotheses
been
proposed,
including
role
tau
protein
abnormalities,
mitochondrial
dysfunction,
and
chronic
neuroinflammation.
Additionally,
gut–brain
axis
epigenetic
modifications
gained
attention
as
potential
contributors
AD
progression.
The
limitations
existing
therapies
underscore
need
for
innovative
strategies.
This
study
explores
integration
machine
learning
(ML)
in
drug
discovery
accelerate
identification
novel
targets
candidates.
ML
offers
ability
navigate
AD’s
complexity,
enabling
rapid
analysis
extensive
datasets
optimizing
clinical
trial
design.
synergy
between
these
themes
presents
promising
future
more
effective
Language: Английский
Hydrazide-Hydrazone Derivatives and Their Antitubercular Activity
Russian Journal of Bioorganic Chemistry,
Journal Year:
2025,
Volume and Issue:
51(1), P. 35 - 52
Published: Feb. 1, 2025
Language: Английский
Virtual screening and molecular dynamics of anti-Alzheimer compounds from Cardiospermum halicacabum via GC-MS
Selvan Kaviyarasu,
No information about this author
Nallamuthu Padmanaban,
No information about this author
Sulekha Khute
No information about this author
et al.
Frontiers in Chemistry,
Journal Year:
2025,
Volume and Issue:
13
Published: April 4, 2025
Background
Ayurveda
is
an
ancient
Indian
medicinal
system
that
uses
plants
for
their
neuroprotective
effects.
claims
the
(
C.
halicacabum
)
leaves
possess
significant
properties.
Alzheimer’s
characterized
by
accumulation
of
amyloid-β,
acetylcholinesterase,
and
tau
tangles
interfere
with
neural
transmission
impair
cognitive
abilities.
Objectives
This
study
aimed
to
identify
novel
potential
anti-Alzheimer
phytoconstituents
using
in
silico
methods.
Methods
utilized
Box–Behnken
design
within
response
surface
methodology
(RSM)
optimize
combine
effects
process
variables,
namely
powder
weight,
solvent
volume,
extraction
time,
on
microwave-assisted
(MAE)
leaves.
The
optimization
revealed
these
along
microwave
usage,
significantly
influenced
yield.
ethanolic
extract
was
examined
gas
chromatography-mass
spectrometry
(GC–MS)
analysis,
identified
were
further
analyzed
through
computer-based
simulations,
including
docking,
absorption,
distribution,
metabolism,
excretion,
toxicity
(ADMET)
studies,
assessment
drug-likeness,
molecular
dynamics,
LigPlot
density
functional
theory
(DFT)
analysis.
Results
Gas
(GC-MS)
analysis
40
37
successfully
characterized.
Molecular
docking
dynamics
simulations
two
lead
compounds,
acetic
acid
(dodecahydro-7-hydroxy-1,4b,8,8-tetramethyl-10-oxo-2(1H)-phenanthrenylidene)-,2-(dimethylamino)ethyl
ester,
[1R-(1.
alpha)],
1-(2-hydroxyethoxy)-2-methyldodecane,
which
exhibited
superior
stability
docked
complex
compared
galantamine.
Conclusion
Based
computational
predictions
observed
pharmacological
properties,
findings
suggest
may
have
therapeutic
against
selected
AD
targets.
Language: Английский